← Leaderboards
Julie M Overbaugh
University Of Washington
$57,026,393
Attributed
$57,041,393
Total exposure
20
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,891,811 · 21
By mechanism
R01$32,805,082 · 9
R37$12,889,122 · 1
P01$12,156,167 · 3
DP1$4,391,200 · 1
T32$2,116,428 · 1
P30$693,806 · 1
Top collaborators
- Raymond Scott Mcclelland1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Grace C John-Stewart$42,921,726
- Robert W. Coombs$29,428,054
- Patricia A Totten$9,808,787
- Lisa M Frenkel$29,105,317
- Nancy B. Kiviat$21,349,193
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionVirusCohortVariantHiv InfectionsSamplingResponseViralAntibodiesTransmission ProcessVaccinesDesignWomanHiv-1Neutralizing AntibodySpecificityCohort StudiesInsightPropertyPlasmaCellsEpitopesHiv VaccineImmune Response
Grant awards (117)
Clonal lineage tracing of HIV specific NK memory cells$220,000
R21 · FY2025 · AI · contact PI
Characterization of a new CXCR4-specific restriction factor$220,000
R21 · FY2025 · AI · contact PI
Early and Reinfection in High Risk Women$916,759
R01 · FY2024 · HD · contact PI
Characterization of a new CXCR4-specific restriction factor$237,600
R21 · FY2024 · AI · contact PI
Early and Reinfection in High Risk Women$916,759
R01 · FY2023 · HD · contact PI
The role of antibodies in mother to child HIV transmission$659,708
R01 · FY2023 · AI · contact PI
Early and Reinfection in High Risk Women$927,205
R01 · FY2022 · HD · contact PI
Characterizing the broad antibody response to HIV superinfection$802,400
R01 · FY2022 · AI · contact PI
The role of antibodies in mother to child HIV transmission$659,708
R01 · FY2022 · AI · contact PI
Cancer Research Career Enhancement and Related Activities$347,968
P30 · FY2022 · CA · contact PI
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathways$123,360
R01 · FY2022 · AI · contact PI
Early and Reinfection in High Risk Women$929,397
R01 · FY2021 · HD · contact PI
Characterizing the broad antibody response to HIV superinfection$802,400
R01 · FY2021 · AI · contact PI
The role of antibodies in mother to child HIV transmission$659,708
R01 · FY2021 · AI · contact PI
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathways$489,662
R01 · FY2021 · AI · contact PI
Viral Pathogenesis and Evolution Training Program (VPETP)$261,687
T32 · FY2021 · AI · contact PI
Early and Reinfection in High Risk Women$967,397
R01 · FY2020 · HD · contact PI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV$839,137
R01 · FY2020 · AI · contact PI
Characterizing the broad antibody response to HIV superinfection$802,400
R01 · FY2020 · AI · contact PI
The role of antibodies in mother to child HIV transmission$662,292
R01 · FY2020 · AI · contact PI
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathways$355,912
R01 · FY2020 · AI · contact PI
Cancer Research Career Enhancement and Related Activities$345,838
P30 · FY2020 · CA · contact PI
Viral Pathogenesis and Evolution Training Program (VPETP)$258,237
T32 · FY2020 · AI · contact PI
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION$880,000
DP1 · FY2019 · DA · contact PI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV$839,137
R01 · FY2019 · AI · contact PI
Characterizing the broad antibody response to HIV superinfection$802,400
R01 · FY2019 · AI · contact PI
Early and Reinfection in High Risk Women$789,642
R37 · FY2019 · AI · contact PI
The role of antibodies in mother to child HIV transmission$695,124
R01 · FY2019 · AI · contact PI
Viral Pathogenesis and Evolution Training Program (VPETP)$254,451
T32 · FY2019 · AI · contact PI
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION$880,000
DP1 · FY2018 · DA · contact PI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV$839,137
R01 · FY2018 · AI · contact PI
Characterizing the broad antibody response to HIV superinfection$821,274
R01 · FY2018 · AI · contact PI
Early and Reinfection in High Risk Women$789,642
R37 · FY2018 · AI · contact PI
Viral Pathogenesis Training Program$170,359
T32 · FY2018 · AI · contact PI
Mombasa HIV/STD Research Site 25th Anniversary Symposium$30,000
R13 · FY2018 · AI
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION$880,000
DP1 · FY2017 · DA · contact PI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV$839,137
R01 · FY2017 · AI · contact PI
Early and Reinfection in High Risk Women$789,642
R37 · FY2017 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$575,449
R01 · FY2017 · AI · contact PI
Viral Pathogenesis Training Program$170,204
T32 · FY2017 · AI · contact PI
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION$871,200
DP1 · FY2016 · DA · contact PI
Early and Reinfection in High Risk Women$789,642
R37 · FY2016 · AI · contact PI
DEFINING THE INFANT IMMUNE RESPONSE TO HIV$787,267
R01 · FY2016 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$635,652
R01 · FY2016 · AI · contact PI
Viral Pathogenesis Training Program$137,638
T32 · FY2016 · AI · contact PI
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION$880,000
DP1 · FY2015 · DA · contact PI
Early and Reinfection in High Risk Women$798,075
R37 · FY2015 · AI · contact PI
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN$673,805
R01 · FY2015 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$657,777
R01 · FY2015 · AI · contact PI
Viral Pathogenesis Training Program$166,212
T32 · FY2015 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$19,481
R01 · FY2015 · AI · contact PI
EARLY AND REINFECTION IN HIGH RISK WOMEN$694,606
R37 · FY2014 · AI · contact PI
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN$673,805
R01 · FY2014 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$575,449
R01 · FY2014 · AI · contact PI
Viral Pathogenesis Training Program$163,490
T32 · FY2014 · AI · contact PI
MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN$1,674,581
P01 · FY2013 · HD · contact PI
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN$735,297
R01 · FY2013 · AI · contact PI
EARLY AND REINFECTION IN HIGH RISK WOMEN$686,720
R37 · FY2013 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$559,922
R01 · FY2013 · AI · contact PI
Administrative Core$402,185
P01 · FY2013 · HD · contact PI
The Role of Inflammation and Immune Activation in HIV-1 Infection In Women$203,400
P01 · FY2013 · HD · contact PI
Viral Pathogenesis Training Program$117,674
T32 · FY2013 · AI · contact PI
MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN$1,767,383
P01 · FY2012 · HD · contact PI
EARLY AND REINFECTION IN HIGH RISK WOMEN$751,076
R37 · FY2012 · AI · contact PI
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN$677,450
R01 · FY2012 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$483,694
R01 · FY2012 · AI · contact PI
Administrative Core$414,163
P01 · FY2012 · HD · contact PI
The Role of Inflammation and Immune Activation in HIV-1 Infection In Women$209,921
P01 · FY2012 · HD · contact PI
Viral Pathogenesis Training Program$138,231
T32 · FY2012 · AI · contact PI
MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN$1,774,965
P01 · FY2011 · HD · contact PI
EARLY AND REINFECTION IN HIGH RISK WOMEN$974,201
R37 · FY2011 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$485,287
R01 · FY2011 · AI · contact PI
Characterization of HIV-1 Antibody Responses in Chronically Infected Women$452,120
R01 · FY2011 · HD · contact PI
Administrative Core$412,305
P01 · FY2011 · HD · contact PI
The Role of Inflammation and Immune Activation in HIV-1 Infection In Women$212,551
P01 · FY2011 · HD · contact PI
Viral Pathogenesis Training Program$137,388
T32 · FY2011 · AI · contact PI
MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN$1,822,294
P01 · FY2010 · HD · contact PI
EARLY AND REINFECTION IN HIGH RISK WOMEN$840,402
R37 · FY2010 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$489,778
R01 · FY2010 · AI · contact PI
Administrative Core$463,735
P01 · FY2010 · HD · contact PI
Characterization of HIV-1 Antibody Responses in Chronically Infected Women$457,463
R01 · FY2010 · HD · contact PI
The Role of Inflammation and Immune Activation in HIV-1 Infection In Women$276,319
P01 · FY2010 · HD · contact PI
Viral Pathogenesis Training Program$70,649
T32 · FY2010 · AI · contact PI
MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN$1,811,195
P01 · FY2009 · HD · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$481,391
R01 · FY2009 · AI · contact PI
Administrative Core$473,746
P01 · FY2009 · HD · contact PI
Characterization of HIV-1 Antibody Responses in Chronically Infected Women$449,406
R01 · FY2009 · HD · contact PI
The Role of Inflammation and Immune Activation in HIV-1 Infection In Women$237,424
P01 · FY2009 · HD · contact PI
Viral Pathogenesis Training Program$70,208
T32 · FY2009 · AI · contact PI
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$627,011
R37 · FY2008 · AI · contact PI
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSION$456,703
R01 · FY2008 · AI · contact PI
Characterization of HIV-1 Antibody Responses in Chronically Infected Women$437,103
R01 · FY2008 · HD · contact PI
Lentiviral Variation and AIDS$356,257
R01 · FY2008 · AI · contact PI
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$620,540
R37 · FY2007 · AI · contact PI
Characterization of HIV-1 Antibody Responses in Chronically Infected Women$459,329
R01 · FY2007 · HD · contact PI
Lentiviral Variation and AIDS$363,329
R01 · FY2007 · AI · contact PI
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$617,862
R37 · FY2006 · AI · contact PI
Lentiviral Variation and AIDS$374,353
R01 · FY2006 · AI · contact PI
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$601,374
R37 · FY2005 · AI
Lentiviral Variation and AIDS$289,240
R01 · FY2005 · AI
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$602,109
R37 · FY2004 · AI
REGULATION OF FELV REPLICATION AND PATHOGENESIS$297,590
R01 · FY2004 · CA
PREVENTION OF HIV SHEDDING IN WOMEN--TRIAL OF VITAMIN A$538,412
R01 · FY2003 · AI
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$511,053
R37 · FY2003 · AI
REGULATION OF FELV REPLICATION AND PATHOGENESIS$297,789
R01 · FY2003 · CA
LENTIVIRAL VARIATION AND AIDS$474,073
R01 · FY2002 · AI
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$449,041
R37 · FY2002 · AI
PREVENTION OF HIV SHEDDING IN WOMEN--TRIAL OF VITAMIN A$440,814
R01 · FY2002 · AI
REGULATION OF FELV REPLICATION AND PATHOGENESIS$297,979
R01 · FY2002 · CA
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$484,605
R37 · FY2001 · AI
LENTIVIRAL VARIATION AND AIDS$460,266
R01 · FY2001 · AI
REGULATION OF FELV REPLICATION AND PATHOGENESIS$298,163
R01 · FY2001 · CA
INFECTION OF PIGTAILED MACAQUES W/ SIV/MNE VARIANTS$0
P51 · FY2001 · RR
EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1$471,879
R37 · FY2000 · AI
LENTIVIRAL VARIATION AND AIDS$446,860
R01 · FY2000 · AI
REGULATION OF FELV REPLICATION AND PATHOGENESIS$295,916
R01 · FY2000 · CA
INFECTION OF MACACA NEMESTRINA W/ SIV/MNE$132,406
P51 · FY2000 · RR